
- /
- Supported exchanges
- / NSE
- / SUNPHARMA.NSE
Sun Pharmaceutical Industries Limited (SUNPHARMA NSE) stock market data APIs
Sun Pharmaceutical Industries Limited Financial Data Overview
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sun Pharmaceutical Industries Limited data using free add-ons & libraries
Get Sun Pharmaceutical Industries Limited Fundamental Data
Sun Pharmaceutical Industries Limited Fundamental data includes:
- Net Revenue: 525 784 M
- EBITDA: 150 862 M
- Earnings Per Share: 45
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-22
- EPS/Forecast: 11.49
Get Sun Pharmaceutical Industries Limited End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sun Pharmaceutical Industries Limited News

Concert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout Offer
Shares of Concert Pharmaceuticals, Inc. CNCE were up 17.4% last week on its proposed acquisition by India-based Sun Pharmaceutical Industries Ltd. On Jan 19, Concert Pharmaceuticals announced a defini...


5 big deal reports: Sun Pharma’s $576M pact for Concert Pharma
By Davit Kirakosyan Investing.com -- Among the biggest deal dispatches this past week, Sun Pharmaceutical said it would take out Concert Pharma, and Microsoft’s bid to acquire Activision may face a...

Why Concert Pharmaceuticals Stock Rocketed Higher This Week
If all goes according to plan, Concert Pharmaceuticals (NASDAQ: CNCE) will soon cease to be an independent company. The biotech signed a deal to be acquired by a peer; as a result, its share price lea...

India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones
Sun Pharmaceutical Industries Limited, India's top pharmaceutical company, has agreed to acquire Concert Pharmaceuticals Inc (NASDAQ: CNCE) for an upfront payment of $8.00 per share, or $576 million i...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.